Emotional Awareness and Expression Therapy for Patients With Persistent Physical Symptoms in Routine Psychiatric Care: A Pilot Study (EAET for PPS)

Daniel Maroti

Status

Not yet enrolling

Conditions

Somatic Symptom Disorder (DSM-5)

Functional Somatic Disorder

Functional Somatic Syndromes

Persistent Physical Symptoms (PPS)

Treatments

Behavioral: Emotional Awareness and Expression Therapy (EAET)

Study type

Interventional

Funder types

Other

Identifiers

NCT06631911

1111

EAET for PPS: a pilot study

5631

Details and patient eligibility

About

Emotional Awareness and Expression Therapy (EAET) has emerged as a promising approach for addressing persistent physical symptoms (PPS). Investigating EAET within the context of routine psychiatric care is crucial for several reasons:

Many patients with PPS experience significant distress and functional impairment, yet traditional medical treatments often fail to provide adequate relief. Integrating EAET into routine care could offer a valuable therapeutic option for this population.

Preliminary studies suggest that EAET can lead to significant reductions in pain and other somatic symptoms. Investigating its effectiveness in routine care settings could enhance treatment outcomes for patients who have not responded to conventional therapies.

There is often a disconnect between mental health and physical health treatment in routine care. Investigating EAET can help bridge this gap, fostering collaboration between mental health professionals and primary care providers to address the complexities of patients&#39; health issues.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

The participant certifies that they have undergone a medical assessment for their physical symptoms (see separate certificate).
The participant rates either moderate distress from physical symptoms on the PHQ-15 questionnaire (over 10 points) or significant distress from a single physical symptom (at least 2 points for that symptom).
The participant expresses interest in exploring whether emotional factors, such as stress, may contribute to their symptom profile.
Any prescribed medications must have been stable for at least one month.

Exclusion criteria

Participants suffer from ongoing substance abuse (alcohol or drugs) or are assessed to have severe mental health issues (psychotic disorders, moderate to high suicide risk, antisocial personality disorder, etc.).
Participants are currently prescribed medications that are clearly addictive and sedative in nature (e.g., benzodiazepines).
Participants are involved in other psychological treatments focused on physical symptoms. However, other psychological treatments are permitted as long as the supportive therapy does not occur more than once a month.
Participants do not have sufficient proficiency in the Swedish language.

Please note that it is the chief physician of each respective research sponsor who, based on collected anamnesis and self-assessment information, makes the final decision regarding whether a participant should be included or excluded from the research project.